ASCO GI 2021 | Patient-derived organoids as models for chemoradiation response prediction in GI malignancies

Hans Prenen, MD, PhD, UZ Leuven, Leuven, Belgium, discusses the use of organoids as a physiologically relevant predictive in vitro model for patients with gastrointestinal (GI) malignancies, in order to predict response to chemoradiation. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).